Showing 1,681 - 1,700 results of 53,189 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( a ((non decrease) OR (nn decrease)) ))', query time: 0.80s Refine Results
  1. 1681

    Design and analysis of PV fed high-voltage gain DC-DC converter using PI and NN controllers by Madisa V.G., Varaprasad

    Published 2022
    “…When the converter switch comes under active state two capacitors are discharged in series, similarly when the converter switch under inactive state those two capacitors are charged in parallel through the coupled inductor (CI) energy so, to get a high voltage at the converter output side. To reuse the leakage-inductor (LI) energy of the CI with the help of a passive clamp circuit for reducing the voltage stress across the switch, similarly switch has less resistance so conduction losses also decreased. …”
    Get full text
    Get full text
    Get full text
    article
  2. 1682

    Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

    Published 2017
    “…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C<sup>+</sup> and CD163<sup>+</sup> macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C<sup>+</sup>, CD163<sup>+</sup>: proinflammatory macrophage cell-surface markers.…”
  3. 1683
  4. 1684

    DataSheet_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.pdf by Yun Ji (464484)

    Published 2022
    “…In a Syrian golden hamster model of SARS-CoV-2 infection, animals receiving combination of amubarvimab and romlusevimab either pre- or post-infection demonstrated less weight loss, significantly decreased viral load in the lungs, and reduced lung pathology compared to controls. …”
  5. 1685
  6. 1686
  7. 1687
  8. 1688
  9. 1689
  10. 1690

    Rac and PKB activities are required for a late phase of cerebellar LTP. by Claire Jackson (362873)

    Published 2010
    “…<p><b>A</b>) Addition of the Rac inhibitor EHT1864 (50 µM; n = 7) to pipette solution decreases LTP duration. …”
  11. 1691

    Decreased VEGF secretion by inhibiting p38 MAPK, Erk, or AP-1 pathways. by Hiroto Terasaki (104937)

    Published 2013
    “…<p>Inhibition of p38 MAPK (A and B), Erk (C and D), or AP-1 (E and F) significantly decreases the secretion of VEGF in both non-polarized and polarized RPE cells <i>(P</i><0.01, Student’s <i>t</i> tests). …”
  12. 1692
  13. 1693
  14. 1694
  15. 1695
  16. 1696
  17. 1697

    Influenza virus infection decreases CLEC7A (Dectin1) mRNA and reduces phagocytosis of zymosan by AM. by Jieru Wang (179734)

    Published 2012
    “…PR/8 infection induced a dose-dependent decrease of uptake of zymosan. …”
  18. 1698

    Non-dairy cashew nut milk as a matrix to deliver probiotic bacteria by Laura Maria BRUNO (8141640)

    Published 2021
    “…<div><p>Abstract Cashew nut milk was evaluated as a matrix to deliver commercial probiotic strains (Bifidobacterium animalis, Lactobacillus acidophilus and Lactobacillus plantarum) in order to develop a non-dairy probiotic beverage. …”
  19. 1699
  20. 1700

    Equilibrium genotype distributions in a mesa landscape for strongly and non-recombining populations. by Alexander Klug (7252493)

    Published 2019
    “…(A) Lumped mutation class frequencies on linear scales. …”